Metraipolis › archive › dc_60585faedc75

Efficacy and Mechanisms of CDK4/6 Inhibitors in Breast Cancer: Advancing Targeted Therapeutic Strategies — Europe PMC PMID:41930171

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41930171
DOI
10.32604/or.2026.073601
License (as archived)
solo-consultazione
Archived
2026-11-04T02:12:57.509Z
SHA-256 of the archived text
876a433b98fac40a1e88ade5b499704f8014db48ab8cebe02a9447dfc2a426cc
Stable URL of this page
https://metraipolis.com/documento/dc_60585faedc75

How to cite

Efficacy and Mechanisms of CDK4/6 Inhibitors in Breast Cancer: Advancing Targeted Therapeutic Strategies — Europe PMC PMID:41930171 — Europe PMC (en), https://europepmc.org/article/MED/41930171 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_60585faedc75 (Metraipolis archive dc_60585faedc75, sha256 876a433b98fac40a1e88ade5b499704f8014db48ab8cebe02a9447dfc2a426cc)
BibTeX
@misc{dc60585faedc75,
  title = {Efficacy and Mechanisms of CDK4/6 Inhibitors in Breast Cancer: Advancing Targeted Therapeutic Strategies — Europe PMC PMID:41930171},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41930171},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_60585faedc75; sha256 876a433b98fac40a1e88ade5b499704f8014db48ab8cebe02a9447dfc2a426cc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41930171. Agents can read the archived copy with the MCP tool read_document.